Lu_2025_Mar.Drugs_23_

Reference

Title : Isolation and Purification of Novel Antioxidant Peptides from Mussel (Mytilus edulis) Prepared by Marine Bacillus velezensis Z-1 Protease - Lu_2025_Mar.Drugs_23_
Author(s) : Lu J , Shi P , Cao Y , Shi B , Shen H , Zhao S , Gao Y , Chi H , Wang L , Shi Y
Ref : Mar Drugs , 23 : , 2025
Abstract :

Mussels are nutrient-rich but perishable, resulting in substantial resource loss. A protease-producing strain (Bacillus velezensis Z-1, Mytilus edulis) isolated from marine sludge was used to hydrolyze mussels, producing Y-1, a hydrolysate with antioxidant activity. In this study, ultrafiltration, gel chromatography, and LC-MS/MS were employed to isolate and identify bioactive peptides from the hydrolysate. The results revealed that the hydrolysate exhibited antioxidant activity, pancreatic cholesterol esterase inhibitory activity, pancreatic lipase inhibitory activity, and alpha-glucosidase inhibitory activity. Molecular docking using AutoDock Tools 1.5.6 was performed to analyze the interactions of peptides with CD38 and Keap1, leading to the identification of five potentially bioactive peptides: VPPFY, IMLFP, LPFLF, FLPF, and FPRIM. These peptides formed hydrogen bonds and hydrophobic interactions with CD38 and Keap1, demonstrating strong DPPH radical scavenging and superoxide anion radical scavenging capacities. This study highlights the multifunctional bioactive potential of these peptides, offering insights into their therapeutic applications. The findings provide a novel approach for the effective utilization of mussel resources and highlight their potential application value in the development of functional foods.

PubMedSearch : Lu_2025_Mar.Drugs_23_
PubMedID: 40863611

Related information

Citations formats

Lu J, Shi P, Cao Y, Shi B, Shen H, Zhao S, Gao Y, Chi H, Wang L, Shi Y (2025)
Isolation and Purification of Novel Antioxidant Peptides from Mussel (Mytilus edulis) Prepared by Marine Bacillus velezensis Z-1 Protease
Mar Drugs 23 :

Lu J, Shi P, Cao Y, Shi B, Shen H, Zhao S, Gao Y, Chi H, Wang L, Shi Y (2025)
Mar Drugs 23 :